Structures by: Mohandas T.
Total: 14
Allyl 6-amino-5-cyano-2-methyl-4-phenyl-4<i>H</i>-pyran-3-carboxylate
C17H16N2O3
IUCrData (2019) 4, 1 0-0
a=8.2151(5)Å b=9.2850(5)Å c=11.6086(7)Å
α=108.184(4)° β=103.004(4)° γ=105.089(2)°
2-Amino-3-cyano-4-(2,6-dichlorophenyl)-7-hydroxy-4<i>H</i>-\ benzo[1,2-<i>b</i>]pyran
C16H9Cl2N2O2
Acta Crystallographica Section E (2019) 75, 10 1568-1572
a=6.271(3)Å b=8.697(5)Å c=13.794(7)Å
α=107.06(2)° β=94.269(17)° γ=95.00(3)°
2-Amino-3-cyano-4-(3,4-dichlorophenyl)-7-hydroxy-4<i>H</i>-benzo[1,2-<i>b</i>]pyran 1,4-dioxane monosolvate
C16H9Cl2N2O2,C4H8O2
Acta Crystallographica Section E (2019) 75, 10 1568-1572
a=12.753(9)Å b=6.665(4)Å c=24.050(14)Å
α=90° β=102.95(3)° γ=90°
Isobutyl 4-(2-chlorophenyl)-5-cyano-6-{(<i>E</i>)-[(dimethylamino)methylidene]amino}-2-methyl-4<i>H</i>-pyran-3-carboxylate
C21H24ClN3O3
Acta Crystallographica Section E (2015) 71, 2 o101-o102
a=15.6836(16)Å b=15.2523(13)Å c=9.3283(8)Å
α=90.00° β=105.016(2)° γ=90.00°
(<i>E</i>)-4-(Acetoxyimino)-<i>N</i>-allyl-3-isopropyl-2,6-diphenylpiperidine-1-carbothioamide
C26H32N3O2S
Acta Crystallographica Section E (2015) 71, 8 o542-o543
a=12.0434(6)Å b=14.0479(7)Å c=15.2740(7)Å
α=82.161(2)° β=72.463(2)° γ=80.094(2)°
1-(4-Methoxyphenyl)-2-[4-(trifluromethyl)phenyl]-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C29H19F3N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1293-4
a=11.7063(9)Å b=20.2301(16)Å c=9.5419(8)Å
α=90.00° β=99.725(2)° γ=90.00°
2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C28H19FN2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o368
a=9.6430(3)Å b=9.8980(3)Å c=12.3070(4)Å
α=77.4320(10)° β=71.6210(10)° γ=73.1580(10)°
1-(3,5-Dimethylphenyl)-2-(4-fluorophenyl)-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C29H21FN2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o367
a=8.5680(2)Å b=10.6070(3)Å c=23.6900(6)Å
α=90° β=93.8990(10)° γ=90°
Glycine--<i>D</i>-tartaric acid (1/1)
C2H5NO2,C4H6O6
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o236
a=4.8387(2)Å b=9.2913(4)Å c=20.0273(8)Å
α=90.00° β=90.1710(10)° γ=90.00°
1-Phenyl-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>-benzimidazole
C20H13F3N2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o244
a=8.7179(4)Å b=9.6796(5)Å c=11.3612(6)Å
α=67.654(2)° β=68.123(2)° γ=85.013(2)°
2-(4-Methoxyphenyl)-1-phenyl-1<i>H</i>-benzimidazole
C20H16N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o269-70
a=12.3220(3)Å b=7.3030(2)Å c=18.2450(3)Å
α=90° β=108.9090(10)° γ=90°
Methyl ({[(4<i>E</i>)-1,3-dimethyl-2,6-diphenylpiperidin-4-ylidene]amino}oxy)acetate
C22H26N2O3
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 5 o513
a=8.1662(9)Å b=15.0229(16)Å c=16.2889(19)Å
α=90° β=93.903(6)° γ=90°
(<i>E</i>)-3-Methyl-2,6-diphenylpiperidin-4-one <i>O</i>-(3-methylbenzoyl)oxime
C26H26N2O2
Acta Crystallographica Section E (2014) 70, 8 o883
a=10.6265(6)Å b=12.7146(7)Å c=16.4031(8)Å
α=90.00° β=99.524(2)° γ=90.00°
2-(4-(trifluoromethyl)phenyl)-1H-phenanthro[9,10-d]imidazole
C29H19F3N2
Acta Crystallographica Section E (2013) 69, 5 o710
a=8.113(3)Å b=11.733(5)Å c=12.713(2)Å
α=76.3970(10)° β=73.490(2)° γ=86.185(5)°